“The Department of Drug Administration has issued a certificate for 50 lakh doses"
The Directorate General of Drug Administration (DGDA) has given clearance for the vaccine brought by Beximco as no problem was found.
DG of the Directorate General of Drug Administration Major General Mahbubur Rahman made the remarks to the media on Tuesday afternoon.
"The Department of Drug Administration has issued a certificate for 50 lakh doses. This is a certificate of suitability for use," he said.
The first dry run of the Covid-19 vaccine developed by AstraZeneca-Oxford University and manufactured by the Serum Institute of India, will be held 3pm today at Kurmitola General Hospital as Bangladesh gears up for nationwide vaccination drive with Covishield.
On 5 November 2020, the health ministry signed a tripartite Memorandum of Understanding with the Serum Institute in India and Beximco to import the vaccine developed by Oxford-AstraZeneca.
The first consignment of 50 lakh doses of Oxford-AstraZeneca Covid-19 vaccine, purchased by Bangladesh from the Serum Institute of India Pvt Limited, arrived in the country on Monday.
Earlier on 21 January, the consignment of 20 lakh doses of the Oxford-AstraZeneca vaccine, gifted by India, arrived at Dhaka Airport by air cargo.
Prime Minister Sheikh Hasina will inaugurate the vaccination drive on 27 January at Kurmitola Hospital. A nurse will receive the jab there.